Epidemiology, control and treatment of multiresistant pneumococci

Drugs

Volumn 52, Issue SUPPL. 2, 1996, Pages 42-46

  Klugman, Keith P ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFPIROME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; MEROPENEM; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; TETRACYCLINE; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL MENINGITIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENTIATION; EPIDEMIOLOGY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; OTITIS MEDIA; PNEUMONIA; PREVALENCE; RISK FACTOR; SEIZURE; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0029850147     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600522-00009     Document Type: Conference Paper

References (25)

1. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96
2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83
3. Friedland IR, McCracken Jr GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New Engl J Med 1994; 331: 377-82
4. Klugman KP. Management of antibiotic-resistant pneumococcal infections. J Antimicrob Chemother 1994; 34: 191-3
5. Lonks JR, Medeiros AA. The growing threat of antibiotic-resistant Streptococcus pneumoniae. Med Clin North Am 1995; 79: 523-35
6. Yoshida R, Kaku M, Kohno S, et al. Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan. Antimicrob Agents Chemother 1995; 39: 1196-8
7. Lee H-J, Park J-Y, Jang S-H, et al. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis 1995; 20: 826-35
8. Soares S, Kristinsson KG, Musser JM, et al. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63
9. Ward JI, Moellering Jr RC. Susceptibility of pneumococci to 14 β-lactam agents: comparison of strains resistant, intermediately resistant and susceptible to penicillin. Antimicrob Agents Chemother 1981; 20: 204-7
10. Klugman KP, Koornhof HJ, Kuhnle V. Clinical and pharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child 1986; 140: 1186-90
11. Smith AM, Klugman KP, Coffey TJ, et al. Genetic diversity of penicillin-binding protein 2B and 2X genes of Streptococcus pneumoniae in South Africa. Antimicrob Agents Chemother 1993; 37: 1938-44
12. Coffey TJ, Daniels M, McDougal LK, et al. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded spectrum cephalosporins. Antimicrob Agents Chemother 1995; 39: 1306-13
13. Lopez P, Espinosa M, Lacks SA. Physical structure and genetic expression of the sulphonamide-resistant plasmid pLS 80 and its derivative in Streptococcus pneumoniae and Bacillus subtilis. Mol Gen Genet 1984; 195: 402-10
14. Lacks SA, Greenberg B, Lopez P. A cluster of four genes encoding enzymes for five steps in the folate biosynthetic pathway of Streptococcus pneumoniae. J Bacteriol 1995; 177: 66-74
15. Baquero F, Martinez-Beltran J, Loza E. Review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28: 31-8
16. Friedland IR, Klugman KP. Antibiotic-resistant disease in South African children. Am J Dis Child 1992; 146: 920-3
17. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New Engl J Med 1995; 333: 474-80
18. Burucoa C, Pasdeloup T, Shapon C, et al. Failure of pristinamycin treatment in a case of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 1995; 14: 341-2
19. Barry B, Gehanno P, Blume N, et al. Clinical outcome of acute otitis media caused by pneumococci with decreased susceptibility to penicillin. Scand J Infect Dis 1994; 26: 446-52
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing M100-S5. 5th Informational supplement, NCCLS, Villanova. PA, 1994
21. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1988-92
22. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy oF adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35: 2467-72
23. Wong VK, Wright HT, Ross LA, et al. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J 1991; 10: 122-5
24. Klugman KP, Dagan R, The Meropeneni Meningitis Study Group. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1140-6
25. Klugman KP, Wasas A. In vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae. J Antimicrob Chemother 1995; 36: 873-4